GlobeNews Wire

Junshi Biosciences Announces FDAs Approval of IND Application for Phase 2/3 Clinical Study of JS207 for the Neoadjuvant Treatment of NSCLC Patients

SHANGHAI, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading…

6 months ago

The Hemp Doctor Debuts 6.5G THC Disposable Vape: Bolder & Stronger Than Ever

MOORESVILLE, N.C., Oct. 16, 2025 (GLOBE NEWSWIRE) -- The Hemp Doctor, a trusted leader in premium dispensary-grade hemp-derived products, has…

6 months ago

Revolution Medicines Awarded Voucher for Daraxonrasib (RMC-6236) Under FDA Commissioner’s National Priority Voucher Pilot Program

REDWOOD CITY, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing…

6 months ago

Karta Officially Launches, Partners With More Than a Dozen Financial Institutions to Offer First U.S.-issued Premium Credit Card Designed for Global Non-Residents with a U.S. Bank Account

MIAMI, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Karta, the first and only U.S.-issued premium credit card designed for global non-residents…

6 months ago

Presidio Launches Healthcare Vertical with Flagship HealthSense AI Platform

NEW YORK, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Presidio, a leading technology services and solutions provider, today launched its dedicated…

6 months ago

AAF Management Closes $55M for Early Stage Hybrid Fund

Washington, D.C., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Venture capital firm AAF announced today that it has closed a $55M…

6 months ago

Roche presents major advances for its sequencing by expansion technology(1), including a new GUINNESS WORLD RECORD, at the ASHG conference 2025

Significant progress in bulk RNA sequencing, methylation mapping, multiomics integration, and spatial analyses unlocks research previously out of reach for…

6 months ago

Kuros Biosciences increases the annual guidance for 2025, The company reports 77% year-over-year increase for the first nine months of 2025

Ad hoc announcement pursuant to Article 53 of the SIX listing rules Kuros Biosciences increases the annual guidance for 2025…

6 months ago

CORRECTION: Propanc Biopharma Announces Strategic Financing Agreement of up to $100 Million with Hexstone Capital

MELBOURNE, Australia, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. ("Propanc" or the "Company") is pleased to announce it…

6 months ago

The Next Evolution of the Baby Book: Growbook Launches for Today’s Parents

Seattle, WA , Oct. 15, 2025 (GLOBE NEWSWIRE) -- Growbook, a new digital baby book app designed to transform how…

6 months ago